FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084274 [Registered on: 07/04/2025] Trial Registered Prospectively
Last Modified On: 20/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Clinical Trial to Evaluate the Effectiveness of Shankhapushpi Syrup with or without Applied Behavior Analysis Therapy in Children with Autism Spectrum Disorder 
Scientific Title of Study   Two Arm Open Label Prospective Clinical Study to Evaluate the Efficacy of Shankhapushpi Syrup with and without Applied Behavior Analysis Therapy in Autism Spectrum Disorder in Children 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kamlesh Kumar Meena 
Designation  MD Scholar 
Affiliation  Post Graduate Institute of Ayurveda Jodhpur 
Address  PG Department of Kaumarbhritya Post Graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037 India

Jodhpur
RAJASTHAN
342037
India 
Phone  8559877381  
Fax    
Email  kmeena508@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Harish Kumar Singhal 
Designation  Professor & HOD 
Affiliation  Post Graduate Institute of Ayurveda Jodhpur 
Address  Room no 155 PG Department of Kaumarbhritya Post Graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037 India

Jodhpur
RAJASTHAN
342037
India 
Phone  8619892143  
Fax    
Email  ayurharish14@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Harish Kumar Singhal 
Designation  Professor & HOD 
Affiliation  Post Graduate Institute of Ayurveda Jodhpur 
Address  Room no 155 PG Department of Kaumarbhritya Post Graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037 India

Jodhpur
RAJASTHAN
342037
India 
Phone  8619892143  
Fax    
Email  ayurharish14@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037 India  
 
Primary Sponsor  
Name  Post Graduate Institute of Ayurved DSRRAU Jodhpur 
Address  PG Department of Kaumarbhritya Post Graduate Institute of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037 India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kamlesh Kumar Meena  Post Graduate Institute of Ayurved DSRRAU Jodhpur  PG Department of Kaumarbhritya Post Graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037 India
Jodhpur
RAJASTHAN 
8559877381

kmeena508@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Post Graduate Institute of Ayurved  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F840||Autistic disorder. Ayurveda Condition: UNMADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Applied Behavior Analysis TherapyApplied Behavior Analysis Therapy for 60 days with Shankhpushpi Syrup
2Intervention ArmDrugClassical(1) Medicine Name: Shankhpushpi Syrup, Reference: Charak Samhita Chikitsasthan Chapter 1 Rasayana Adhyay Paad 3 Karapratichiya Rasayanapad Shloka 30, Route: Oral, Dosage Form: Sharkara/ Syrup, Dose: 30(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Lukewarm Water), Additional Information: -
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details  1 Diagnosed cases of Autism satisfying DSM V criteria of both sexes
2 Patients with score above 70 in Indian Scale for assessment of Autism (ISAA)
3 Age between 3 to 16 years of both sexes. 
 
ExclusionCriteria 
Details  1 Patient with score below 70 in Indian Scale for assessment of Autism (ISAA)
2 ASD medications from any other system
3 Patients having mental retardation, cerebral palsy
4 Patients having presence of other organic or psychotic neurological disorder
5 Patients having pervasive developmental disorder
6 Patients having hearing and visual impairment
7 Patients having acute and chronic systemic illness such as renal diseases, hepatic
dysfunction, juvenile diabetes mellitus etc
8 Patients having congenial disorders, genetic syndrome like fragile X syndrome, turner
syndrome etc
9 Patients having progressive and non-progressive neuromuscular disorders 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Shankhpushpi Syrup with and without Applied Behavior
Analysis Therapy will be effective. 
60 Days 
 
Secondary Outcome  
Outcome  TimePoints 
1. Shankhpushpi Syrup with and without Applied Behavior Analysis Therapy will
be helpful to improve quality of life of children suffering from ASD.
2. Change in ISAA score/ DSM V score. 
60 Days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   07/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Number of Patient- 40

Type of Study- Two Arm Open label Prospective Clinical Study

Group :- Two Groups:-
  Group A :- Shankhpushpui syrup
  Group B - Shankhpushpui syrup with Applied Behavior Analysis Therapy

Drug- Shankhapushpui syrup

Dose- Dose will be calculated according to Young Formula in three divided doses. 

Route- Shankhpushpui syrup - Oral Route

Anupana- Oral medicine will be given with Luke warm milk

Randomization- Simple Random Sampling

Duration of Study- 60 days

Follow up- Every fortnightly during the study and 120 days after completion of the study.
 
Close